In this report, according to this study, over the next five years the Gastrointestinal Stromal Tumor (GIST) Drugmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Gastrointestinal Stromal Tumor (GIST) Drugbusiness.
Gastrointestinal Stromal Tumor (GIST) Drug market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Gastrointestinal Stromal Tumor (GIST) Drug market competition by top manufacturers/players, with Gastrointestinal Stromal Tumor (GIST) Drug sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug for each application, including
Clinic
Hospital
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Gastrointestinal Stromal Tumor (GIST) Drug Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Amcasertib
2.1.2 Anagrelide hydrochloride CR
2.1.3 APG-1351
2.1.4 Binimetinib
2.1.5 Others
2.2 Overall Market Performance(Value)
2.2.1 Amcasertib
2.2.2 Anagrelide hydrochloride CR
2.2.3 APG-1351
2.2.4 Binimetinib
2.2.5 Others
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
4 Manufacturers Profiles/Analysis
4.1 Ariad Pharmaceuticals, Inc.
4.1.1 Ariad Pharmaceuticals, Inc. Profiles
4.1.2 Ariad Pharmaceuticals, Inc. Product Information
4.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Ariad Pharmaceuticals, Inc. SWOT Analysis
4.2 Arog Pharmaceuticals, Inc.
4.2.1 Arog Pharmaceuticals, Inc. Profiles
4.2.2 Arog Pharmaceuticals, Inc. Product Information
4.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Arog Pharmaceuticals, Inc. SWOT Analysis
4.3 Array BioPharma Inc.
4.3.1 Array BioPharma Inc. Profiles
4.3.2 Array BioPharma Inc. Product Information
4.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Array BioPharma Inc. SWOT Analysis
4.4 Astex Pharmaceuticals, Inc.
4.4.1 Astex Pharmaceuticals, Inc. Profiles
4.4.2 Astex Pharmaceuticals, Inc. Product Information
4.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Astex Pharmaceuticals, Inc. SWOT Analysis
4.5 Blueprint Medicines Corporation
4.5.1 Blueprint Medicines Corporation Profiles
4.5.2 Blueprint Medicines Corporation Product Information
4.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Blueprint Medicines Corporation SWOT Analysis
4.6 Boston Biomedical, Inc.
4.6.1 Boston Biomedical, Inc. Profiles
4.6.2 Boston Biomedical, Inc. Product Information
4.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Boston Biomedical, Inc. SWOT Analysis
4.7 Calithera Biosciences, Inc.
4.7.1 Calithera Biosciences, Inc. Profiles
4.7.2 Calithera Biosciences, Inc. Product Information
4.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Calithera Biosciences, Inc. SWOT Analysis
4.8 Chipscreen Biosciences Ltd
4.8.1 Chipscreen Biosciences Ltd Profiles
4.8.2 Chipscreen Biosciences Ltd Product Information
4.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Chipscreen Biosciences Ltd SWOT Analysis
4.9 Deciphera Pharmaceuticals, LLC
4.9.1 Deciphera Pharmaceuticals, LLC Profiles
4.9.2 Deciphera Pharmaceuticals, LLC Product Information
4.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Deciphera Pharmaceuticals, LLC SWOT Analysis
4.10 F. Hoffmann-La Roche Ltd.
4.10.1 F. Hoffmann-La Roche Ltd. Profiles
4.10.2 F. Hoffmann-La Roche Ltd. Product Information
4.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) DrugSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 F. Hoffmann-La Roche Ltd. SWOT Analysis
4.11 Horizon Pharma Plc
4.12 Immunicum AB
4.13 Jiangsu Hengrui Medicine Co., Ltd.
4.14 Kolltan Pharmaceuticals, Inc.
4.15 Natco Pharma Limited
4.16 Nerviano Medical Sciences S.r.l.
4.17 Novartis AG
4.18 Omeros Corporation
5 Market Performance for Manufacturers
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Assessment by Regions (2014-2020)
7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) by Regions 2014-2020
7.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Clinic Industry
11.2 Hospital Industry
11.3 Others Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Amcasertib
12.2.3 Anagrelide hydrochloride CR
12.2.4 APG-1351
12.2.5 Binimetinib
12.2.6 Others
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Clinic
12.3.3 Hospital
12.3.4 Others
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) Trend 2021-2026
12.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Profit Trend 2021-2026
13 Conclusion